Abstract:Rationale: The initial hypertrophy response to cardiac pressure overload is considered compensatory, but with sustained stress, it eventually leads to heart failure. Recently, a role for recruited macrophages (mψs) in determining the transition from compensated to decompensated hypertrophy has been established. However, whether cardiac-resident immune cells influence the early phase of hypertrophy development has not been established. Objective: To assess the role of cardiac immune cells in the early hypertrophy response to cardiac pressure overload-induced by transverse aortic constriction (TAC). Methods and Results: We performed cytometry-by-time-of-flight to determine the identity and abundance of immune cells in the heart at 1 and 4 weeks after TAC. We observed a substantial increase in cardiac mψs 1 week after TAC. We then conducted Cite-Seq single-cell RNA sequencing of cardiac immune cells isolated from 4 sham and 6 TAC hearts. We identified 12 clusters of monocytes and mψs, categorized as either resident or recruited mψs, that showed remarkable changes in their abundance between sham and TAC conditions. To determine the role of cardiac-resident mψs early in the response to a hypertrophic stimulus, we used a blocking antibody against macrophage colony-stimulating factor 1 receptor (CD115). As blocking CD115 initially depletes all macrophages, we allowed the replenishment of recruited mψs by monocytes before performing TAC. This preferential depletion of resident mψs resulted in enhanced fibrosis and a blunted angiogenesis response to TAC. Mψ-depletion in CCR2 knockout mice showed that aggravated fibrosis was primarily caused by the recruitment of monocyte-derived mψs. Finally, 6 weeks after TAC these early events lead to depressed cardiac function and enhanced fibrosis, despite complete restoration of cardiac immune cells. Conclusions: Cardiac resident mψs are a heterogeneous population of immune cells with key roles in stimulating angiogenesis and inhibiting fibrosis in response to cardiac pressure overload.

Cardiac resident macrophages: The core of cardiac immune homeostasis

Cardiac resident macrophages: Spatiotemporal distribution, development, physiological functions, and their translational potential on cardiac diseases

Resident macrophages as potential therapeutic targets for cardiac ageing and injury

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

At the heart of inflammation: Unravelling cardiac resident macrophage biology

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Spatiotemporal development and the regulatory mechanisms of cardiac resident macrophages: Contribution in cardiac development and steady state

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

The role of cardiac resident macrophage in cardiac aging

Macrophage-driven Cardiac Inflammation and Healing: Insights from Homeostasis and Myocardial Infarction

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

Role of Cardiac Macrophages in Controlling the Infection and Homeostasis of Steady State Heart Function in Aging

The Characteristic of Resident Macrophages and Their Therapeutic Potential for Myocardial Infarction

Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis

Syncytium calcium signaling and macrophage function in the heart

Resident Macrophages: Near and Dear to Your Heart